Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02062879 · ClinicalTrials.gov registry record · Phase 3
Ketamine Patient-Controlled Analgesia for Acute Pain
A Phase 3 study, sponsored by University of Cincinnati.
- Terminated
- Registry status
- Phase 3
- Development phase
- 20
- Enrollment target
NCT02062879 is a Phase 3 study that was terminated before completion, run by University of Cincinnati. The registered enrollment target is 20 participants.
The verdict
NCT02062879, a Phase 3 study, was terminated before completion, sponsored by University of Cincinnati.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine are also expected to have shorter duration of supplemental oxygen requirement, fewer episodes of oxygen desaturation, improved pulmonary toilet, lower use of antiemetics, and shorter times to first bowel movement. Ketamine is further expected to be associated with decreased intensive care unit and hospital lengths of stay, faster time to maximum allowable ambulation, decreased opioid dosage at discharge, and lower report of chronic pain syndromes.
Interventions
- DRUG Ketamine
- DRUG Hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-04 |
| Est. Completion | 2016-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02062879
The ClinicalTrials.gov registry entry for NCT02062879 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ketamine is the first listed.
NCT02062879 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02062879 about?
NCT02062879 is a clinical study titled "Ketamine Patient-Controlled Analgesia for Acute Pain". This study will compare ketamine and hydromorphone as alternative patient-controlled interventions for trauma-related pain. Patients receiving ketamine PCA are expected to require less total and breakthrough opioid and to have similar or improved objective pain scores. Patients receiving ketamine ar...
What is the current status of trial NCT02062879?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 20 participants. The study started on 2014-04. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02062879?
The interventions under investigation include: Ketamine (DRUG), Hydromorphone (DRUG).
Who is sponsoring clinical trial NCT02062879?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.